HEALTH-STATUS REPORTS IN THE CARE OF PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:93
|
作者
KAZIS, LE
CALLAHAN, LF
MEENAN, RF
PINCUS, T
机构
[1] BOSTON UNIV,SCH MED,CTR MULTIPURPOSE ARTHRITIS,80 E CONCORD ST,BOSTON,MA 02118
[2] BOSTON CITY HOSP,DEPT MED,BOSTON,MA 02118
[3] BOSTON UNIV HOSP,DEPT MED,BOSTON,MA 02218
[4] VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,DIV RHEUMATOL & IMMUNOL,NASHVILLE,TN 37232
关键词
Arthritis Impact; Clinical practice; Health Assessment Questionnaire; Health status reports; Measurement Scales; Rheumatoid arthritis;
D O I
10.1016/0895-4356(90)90025-K
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We examined the use of formal health status reports every 3 months over 1 year in the clinical care of patients with rheumatoid arthritis (RA). The reports consisted of single-page, computer-generated summaries of scores derived from either the AIMS (Arthritis Impact Measurement Scales) or the MHAQ (Modified Health Assessment Questionnaire) health status questionnaires. A total of 1920 subjects from 27 community practice sites were randomly assigned to three study groups in each practice: intervention, attention placebo and control. Results showed that 55% of the physicians found the reports to be at least moderately useful as an aid to patient management, primarily for improving the doctor-patient relationship. However, no detectable differences among the three groups were seen in terms of medication compliance, number of physician visits, number of referrals, frequency of major medication changes, attitudes towards the physician, patient satisfaction or change in health status over 1 year. The failure to demonstrate objective benefits of health status reports in this study may be due to physician unfamiliarity with health status scores, failure to link the report with an office visit, the relative stability of clinical status in the subjects over 1 year and the relatively short time-frame of the study. © 1990.
引用
收藏
页码:1243 / 1253
页数:11
相关论文
共 50 条
  • [41] THE PATHOPHYSIOLOGY OF RHEUMATOID-ARTHRITIS
    BODMAN, KB
    ROITT, IM
    FUNDAMENTAL AND CLINICAL IMMUNOLOGY, 1994, 2 (02): : 73 - 81
  • [42] THE PATHOPHYSIOLOGY OF RHEUMATOID-ARTHRITIS
    LYDYARD, PM
    EDWARDS, JCW
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1994, 12 : S55 - S58
  • [43] MORTALITY IN RHEUMATOID-ARTHRITIS
    MYLLYKANGASLUOSUJARVI, RA
    AHO, K
    ISOMAKI, HA
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 25 (03) : 193 - 202
  • [44] EPIDEMIOLOGY OF RHEUMATOID-ARTHRITIS
    KAHN, MF
    REVUE DU RHUMATISME, 1993, 60 (5BIS): : S56 - S60
  • [45] OSTEOPOROSIS IN RHEUMATOID-ARTHRITIS
    DEQUEKER, J
    MAENAUT, K
    VERWILGHEN, J
    WESTHOVENS, R
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 : 21 - 26
  • [46] EPIDEMIOLOGY OF RHEUMATOID-ARTHRITIS
    SILMAN, AJ
    APMIS, 1994, 102 (10) : 721 - 728
  • [47] MONOTHERAPY IN RHEUMATOID-ARTHRITIS
    EMERY, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 : 21 - 23
  • [48] CYTOKINES IN RHEUMATOID-ARTHRITIS
    RIDDERSTAD, A
    ABEDIVALUGERDI, M
    MOLLER, E
    ANNALS OF MEDICINE, 1991, 23 (03) : 219 - 223
  • [49] PHTHALYLSULPHATHIAZOLE IN RHEUMATOID-ARTHRITIS
    ASTBURY, C
    HILL, J
    BIRD, HA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (07): : 461 - 463
  • [50] IMAGING IN RHEUMATOID-ARTHRITIS
    MUNDINGER, A
    MOSER, E
    LANGER, M
    IMMUNITAT UND INFEKTION, 1993, 21 (03): : 64 - 68